Stejbach Mark
Indivior Pharmaceuticals Inc · Director
Stejbach Mark is listed in filings as Director at Indivior Pharmaceuticals Inc. This profile follows SEC Form 4 activity through May 14, 2026, including purchase activity. Recent filings connect the profile to Indivior Pharmaceuticals Inc (INDV). The current snapshot covers public activity from Jan 7, 2026 to May 14, 2026. Reported amounts are shown as $27.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $27k775 shares | BuyJan 5, 2026 | $35.39 | $40.54 |